O'Connor v. Aerco International, Inc.

Appeals (1) from an order of the Supreme Court (Aulisi, J.), entered April 26, 2016 in Saratoga County, which, among other things, granted a motion by defendant

In February 2015, plaintiff Eileen A. O’Connor was diagnosed with pleural mesothelioma. Alleging that her illness stemmed from exposure to equipment containing asbestos while working at the Westchester County Department of Labs and Research (hereinafter WCDLR) from approximately 1975 to 1979, O’Connor, along with her husband, derivatively, commenced this personal injury action in 2015 against, among others, defendants Fisher Scientific Company, LLC, Thomas Scientific, Inc. and VWR International, LLC (hereinafter collectively referred to as defendants). After joinder of issue and discovery, defendants each moved for summary judgment dismissing the complaint and all cross claims against them, contending, among other things, that plaintiffs failed to identify them as the suppliers of the asbestos-containing products in question. Thereafter, in three separate orders, Supreme Court respectively granted defendants’ motions for summary judgment dismissing the complaint against them, finding that plaintiffs failed to adequately identify any defendants as the supplier of the asbestos-containing products at issue. Plaintiffs appeal, and we reverse.

In order to establish entitlement to judgment as a matter of law, defendants bore the initial burden of demonstrating that their respective products “could not have contributed to the causation” of O’Connor’s asbestos-related injuries (Matter of New York City Asbestos Litig., 116 AD3d 545 , 545 [2014]; see Matter of New York City Asbestos Litig., 216 AD2d 79 , 80 [1995]). Moreover, a defendant cannot satisfy this burden by merely pointing to gaps in a plaintiff’s proof (see Overocker v Madigan, 113 AD3d 924 , 925 [2014]; DiBartolomeo v St. Peter’s Hosp. of the City of Albany, 73 AD3d 1326 , 1327 [2010]; Dow v Schenectady County Dept. of Social Servs., 46 AD3d 1084 , 1084 [2007]; Johnson City Cent. School Dist. v Fidelity & Deposit Co. of Md., 272 AD2d 818 , 821 [2000]). “Failure to make such prima facie showing requires a denial of the motion, regardless of the sufficiency of the opposing papers” (Alvarez v Prospect Hosp., 68 NY2d 320 , 324 [1986]). Stated another way, a defend

In this regard, the proof submitted by defendants, respectively, failed to establish that they did not sell asbestos-containing products to WCDLR during the time that O’Connor was employed or that O’Connor was not exposed to any such products (compare Pellegrino v A.C. & S., Inc., 15 AD3d 377 , 377 [2005]). Defendants submitted plaintiffs’ responses to interrogatories, wherein plaintiffs listed the products containing asbestos that O’Connor was exposed to and stated that the products were supplied by defendants, among others. Fisher Scientific, in its response to plaintiffs’ interrogatories, stated that, “given the passage of many decades and . . . [its] adherence to reasonable and normal record retention policies,” it did not have records of selling these products to WCDLR. However, although none of the deponents could attest to whether any of defendants’ brand names, trademarks or logos were present on asbestos-containing products during the relevant time period, O’Connor and other WCDLR employees testified that there were products containing asbestos in the lab between 1975 and 1979 and that employees consulted defendants’ supply catalogs, among others, to place orders for these products. One employee also testified that WCDLR had contracts with Fisher Scientific and Thomas Scientific during the relevant time period, and a buyer for WCDLR from 1972 to 1978 testified that he purchased supplies from defendants on a regular basis.

Viewing this evidence in the light most favorable to plaintiffs and granting them the benefit of every favorable inference, defendants failed to establish, prima facie, that they could not have caused O’Connor’s asbestos-related illness (see Wells v 3M Co., 137 AD3d 1556 , 1559 [2016]; Matter of New York City Asbestos Litig., 212 AD2d 463 , 464 [1995]). Fisher Scientific’s lack of documentation from the 1970s does not establish that it did not sell asbestos-containing products to WCDLR. Other

Garry, Lynch, Rose and Devine, JJ., concur.

Ordered that the orders are reversed, on the law, with costs, and motions denied.